Dear Readers,
Mahendras has started special quizzes for IBPS | RBI | SBI | NABARD | LIC so that you can practice more and more to crack the examination. This IBPS | RBI | SBI | NABARD | LIC Exam special quiz series will mould your preparations in the right direction, and the regular practice of these quizzes will be very helpful in scoring good marks in the Examination. Here we are providing you with the critical question of English Language for the IBPS | RBI | SBI | NABARD | LIC.
Q.1. Which of the following would be the first sentence after rearrangement?
(1) D
(2) A
(3) C
(4) B
(5) E
Q.2. Which of the following would be the THIRD sentence after rearrangement?
(1) D
(2) C
(3) A
(4) E
(5) B
Q.3. Which of the following would be the SECOND sentence after rearrangement?
(1) D
(2) A
(3) C
(4) B
(5) E
Q.4. Which of the following would be the FIFTH sentence after rearrangement?
(1) D
(2) C
(3) E
(4) A
(5) B
Q.5. Which of the following would be the SIXTH sentence after rearrangement?
(1) F
(2) A
(3) C
(4) E
(5) D
Q.6-10.In the following passage there are blanks each of which has been numbered. These numbers are given below the passage and against each, three words have been suggested. Find out the appropriate word(s) in each case and mark your answer accordingly. Russia’s candidate vaccine for COVID-19 appears to have found a midwife in India. The Russian Direct Investment Fund (RDIF), which is piloting the Sputnik V vaccine, has announced a partnership with the Hyderabad-based Dr. Reddy’s Laboratories to conduct a Phase-3 trial, or large multi-location human trials here.(P)_________ the candidate vaccine, developed by Russia’s Gamaleya, to prove safe and efficacious, the RDIF would supply 100 million doses through its partnership with Dr. Reddy’s Laboratories. However, there is no agreement to manufacture the vaccine here unlike the deal between the Pune-based Serum Institute of India and the United Kingdom-based AstraZeneca, for the Oxford University-developed ChAdOx1 vaccine. Sputnik V is being developed as a two-dose vaccine on a human adenovirus vaccine platform. Several vaccines that are in development are also being deployed on similar platforms, and the evidence so far is that none of these has been commercially approved for use in humans though there is an experimental vaccine for Ebola. Results of the Phase-1 and Phase-2 trials of the vaccine, published in The Lancet, suggest that the evidence so far is that it has proven safe and efficacious enough to progress to the next stage of trials. Controversially, Sputnik V has been granted a pre[1]approval by Russia’s regulators even before Phase-3 trials have been completed. There is(Q)_________ political pressure globally on regulatory agencies to get a vaccine out at the earliest. Thus, it is incumbent on a company conducting such trials to be particularly vigilant that all good practices and necessary protocols are(R)_________ followed. It is well acknowledged that two-thirds of the most common vaccines produced globally are made in India. The Serum Institute has committed to producing 100 million doses of its vaccine for India and other ‘Low and Middle Income Countries’ at less than $3 per dose. Reportedly, half of these are for India. All in all, there seems to be a guarantee for only about 150 million doses for India, which given the country’s population is(S)_________. All of this of course does not account for the vaccines that are being indigenously developed in India: Covaxin, by Bharat Biotech, based on a strain sourced from the Indian Council of Medical Research, and ZyCov-D, the plasmid DNA-vaccine being developed by Zydus Cadilla. In Phase-2 trials now, both are being tested for their ability to produce a satisfactory(T)_________ response.
Q.6. Choose the correct option for (P).
A. Had
B. Provided
C. Were
(1) Only B
(2) Both B and C
(3) Both A and B
(4) Both A and C
(5) Only C
Q.7. Choose the correct option for (Q).
A. Immense
B. Excessive
C. Restricted
(1) Only B
(2) Both B and C
(3) Both A and B
(4) Both A and C
(5) Only C
Q.8. Choose the correct option for (R).
A. Scrupulously
B. Impetuously
C. Meticulously
(1) Only B
(2) Both B and C
(3) Both A and B
(4) Both A and C
(5) Only C
Q.9. Choose the correct option for (S).
A. miniscule
B. significant
C. miniature
(1) Only B
(2) Both B and C
(3) Both A and B
(4) Both A and C
(5) Only C
Q.10. Choose the correct option for (T).
A. immunity
B. immune
C. antibodies
(1) Only B
(2) Both B and C
(3) Both A and B
(4) Both A and C
(5) Only C
Answers
Q.1. (5)
Q.2. (3)
Q.3. (4)
Q.4. (2)
Q.5. (1)
Q.6 (5)
Q.7 (3)
Q.8 (4)
Q.9 (4)
Q.10 (1)
0 comments:
Post a Comment
MAHENDRA GURU